Letermovir: Clinical Trials

1 trial for Letermovir, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1

Follow Letermovir: new trials by email Literature Review of Letermovir trials Research Report on Letermovir

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic Lymphohistiocytosis
Letermovir - EBV-associated T/NK-cell Lymphoproliferative Diseases, Refractory/Relapsed EBV-related Hemophagocytic Lymphohistiocytosis
Not applicableRecruitingBeijing Children's Hospital802025-10-012026-03-23

Interventions

letermovir (1)

Sponsors

Beijing Children's Hospital (1)

Countries

China (1)